Home » Conferences & Events » Health Care » Reimbursement and Health Policy

Reimbursement and Health Policy

The Reimbursement Landscape for Novel Diagnostics: Current Limitations.
January 6, 2011

Personalized medicine has the potential to revolutionize patient care. The fundamental goal in...

BioBytes: The Biotech Drug Delivery Timeline
June 23, 2010

Biotech research holds a great deal of promise for future innovation in the treatment of...

Healing, Fueling, Feeding: How Biotechnology Is Enriching Your Life.
May 1, 2010

Biotechnology is all around us and is already a big part of our lives, providing breakthrough...

BioBytes: What are biosimilars?
January 20, 2010

Biosimilars, also known as follow-on biologics, may eventually expand access and provide...

More Articles →

Letters, Testimony & Comments

340B Program: BIO Comments on Health Resources and Services Administration (HRSA) Notice on the Enrollment and Recertification of Entities in the 340B Pricing Program
May 18 2012
Re:      Proposed Project: Enrollment and Recertification of Entities in the 340B Drug Pricing Program (OMB No....
BIO Comments on CMS Electronic Health Record Incentive Program
May 17 2012
  The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Centers for Medicare and Medicaid...
CED: BIO Public Statement: Medicare Evidence Development & Coverage Advisory Committee Meeting, Evidentiary Characteristics for Coverage with Evidence Development (CED)
April 16 2012
BIO Public Statement Medicare Evidence Development & Coverage Advisory Committee Meeting Evidentiary Characteristics for Coverage...
2012 AMP Proposed Rule: BIO's Comments on the Centers for Medicare and Medicaid Services’ Proposed Rule regarding covered outpatient drugs under the Medicaid Program
April 2 2012
Re:      CMS-2345-P (Proposed Rule, Medicaid Program; Covered Outpatient Drugs) Dear Ms. Tavenner: The...
PCORI Draft National Priorities and Research Agenda: BIO's Comments
March 15 2012
RE: Patient-Centered Outcomes Research Institute (PCORI) Draft National Priorities and Research Agenda Dear Dr. Selby:   ...
More Letters, Testimony & Comments →

Press Releases

BIO Applauds House Committee Vote to Repeal IPAB
March 6 2012
Washington, DC (March 6, 2012) – The Biotechnology Industry Organization (BIO) applauded the House Energy and...
BIO Announces Policy Panel Keynote Session for 2011 BIO International Convention
April 19 2011
WASHINGTON, D.C. (April 19, 2011) - Democratic and Republican party leaders and strategists will share their...
The Future of Healthcare Policy to be Plenary Discussion at 13th Annual BIO CEO & Investor Conference
February 9 2011
WASHINGTON, D.C. (Wednesday, February 09, 2011) -The Biotechnology Industry Organization (BIO) today announced that...
Challenges in Reimbursement Hamper Development of Novel Diagnostics
January 6 2011
WASHINGTON, D.C. (Thursday, January 06, 2011) - The Biotechnology Industry Organization (BIO) released today a report...
Media Registration for the 2011 BIO International Convention Now Available Online
January 3 2011
WASHINGTON, D.C. (Monday, January 03, 2011) - The Biotechnology Industry Organization (BIO) announced today that...
More Press Releases →